PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
9.72%
Net income growth under 50% of MRVL's 81.42%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
No Data
No Data available this quarter, please select a different quarter.
-168.00%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
53.66%
SBC growth well above MRVL's 15.85%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-247.40%
Negative yoy working capital usage while MRVL is 160.18%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-190.30%
AR is negative yoy while MRVL is 157.88%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-105.13%
Negative yoy inventory while MRVL is 536.72%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
303.45%
AP growth well above MRVL's 93.49%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-505.75%
Both reduce yoy usage, with MRVL at -151.59%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-190.91%
Both negative yoy, with MRVL at -92.11%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-51.48%
Negative yoy CFO while MRVL is 55.49%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
1.23%
Lower CapEx growth vs. MRVL's 29.33%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-100.00%
Negative yoy acquisition while MRVL stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
68.79%
Purchases growth of 68.79% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
437.05%
Liquidation growth of 437.05% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
96.79%
We have some outflow growth while MRVL is negative at -100.76%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
143.00%
We have mild expansions while MRVL is negative at -233.50%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
0.13%
Debt repayment well below MRVL's 33.33%. Michael Burry suspects heavier leverage risk or insufficient cash generation to keep pace.
204.17%
Issuance growth of 204.17% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
-235.58%
We cut yoy buybacks while MRVL is 3.97%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.